Please help us improve BubbleLife by flagging content that you find incorrect, inappropriate or irrelevant. Your comments are reviewed by our editors and help us continually improve the quality of the content and discussions.

RE: Sales of Biogen’s costly new Alzheimer’s drug fall far short of expectations.